GSK’s Malaria Vaccine Containing Agenus’ QS-21 Stimulon® Receives Positive Opinion from European Regulators for Prevention of Malaria in Young Children in Sub-Saharan Africa
Go back to GSK’s Malaria Vaccine Containing Agenus’ QS-21 Stimulon® Receives Positive Opinion from European Regulators for Prevention of Malaria in Young Children in Sub-Saharan Africa| AGENUS (NASDAQ: AGEN) | Delayed: 7.85 +0.63 (8.73%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.22 | 52 Week High | $7.49 | |||
| Open | $7.48 | 52 Week Low | $2.61 | |||
| Day High | $7.88 | P/E | N/A | |||
| Day Low | $7.33 | EPS | $-1.10 | |||
| Volume | 2,084,681 | |||||
| GLAXOSMITHKLINE PLC (NYSE: GSK) | Delayed: 50.22 -0.84 (1.65%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $51.06 | 52 Week High | $45.58 | |||
| Open | $50.20 | 52 Week Low | $37.82 | |||
| Day High | $50.33 | P/E | N/A | |||
| Day Low | $49.50 | EPS | $0.00 | |||
| Volume | 4,709,246 | |||||
